Phospho-MARCKS (Ser162) Antibody

What is MARCKS and why is phosphorylation at Ser162 significant?

MARCKS (Myristoylated Alanine-Rich C-Kinase Substrate) is a membrane-associated protein that plays crucial roles in structural modulation of the actin cytoskeleton, chemotaxis, cell motility, adhesion, phagocytosis, and exocytosis through lipid sequestering and protein docking to membranes . The Ser162 phosphorylation site (part of the effector domain) is particularly important because phosphorylation by Protein Kinase C (PKC) at this site causes MARCKS to translocate from the plasma membrane to the cytoplasm, thereby regulating its function in sequestering phosphatidylinositol 4,5-bisphosphate (PIP2) and cross-linking actin filaments .

What applications can Phospho-MARCKS (Ser162) Antibody be used for?

Based on the technical information available, Phospho-MARCKS (Ser162) Antibody can be used in multiple research applications:

• Western Blotting (WB): Dilution 1:100-1:500

• Immunofluorescence (IF/ICC): Dilution 1:100-1:200

• ELISA: Starting concentration of 1 μg/mL (optimize based on assay requirements)

The antibody has been validated for detecting endogenous levels of MARCKS specifically when phosphorylated at serine 162 .

What is the reactivity spectrum of Phospho-MARCKS (Ser162) Antibody?

The antibody demonstrates cross-reactivity with multiple species:

• Human (Homo sapiens)

• Mouse (Mus musculus)

• Rat (Rattus norvegicus)

This broad species reactivity makes it valuable for comparative studies across different model systems.

What are the proper storage and handling conditions?

For optimal antibody performance and longevity:

• Store at -20°C for long-term preservation (recommended)

• Can be stored at 4°C for short-term use up to 6 months

• Avoid repeated freeze-thaw cycles

• The antibody is typically supplied in buffer containing phosphate-buffered saline with glycerol (50%) and sodium azide (0.02%)

How should I validate the specificity of Phospho-MARCKS (Ser162) Antibody?

A robust validation protocol should include:

• Phosphatase Treatment: Compare samples with and without lambda phosphatase treatment. The signal should be eliminated or significantly reduced in phosphatase-treated samples, as demonstrated in validation data for other phospho-MARCKS antibodies .

• Peptide Competition: Pre-incubating the antibody with the phosphopeptide immunogen (K-K-S(p)-F-K) should abolish the signal .

• Stimulation Experiments: Compare samples from cells treated with PKC activators (e.g., PMA) versus untreated controls. Phosphorylation should increase with PKC activation .

• Knockout/Knockdown Controls: Include MARCKS knockout or knockdown samples as negative controls.

What are the recommended protocols for sample preparation when using this antibody?

For optimal detection of phosphorylated MARCKS:

Western Blotting Protocol:

• Lyse cells in buffer containing phosphatase inhibitors (essential)

• Use fresh samples when possible, or snap-freeze immediately after collection

• Load 20-50 μg of total protein per lane

• Transfer to PVDF membrane (recommended over nitrocellulose)

• Block with 5% BSA in TBST (not milk, as it contains phosphatases)

• Incubate with primary antibody at recommended dilution (1:100-1:500) overnight at 4°C

• Visualize at expected molecular weight: 80 kDa for human, 75 kDa for mouse/rat

Immunofluorescence Protocol:

• Fix cells with 4% paraformaldehyde (10 min)

• Permeabilize with 0.1% Triton X-100 (5 min)

• Block with 5% normal serum in PBS

• Incubate with antibody at 1:100-1:200 dilution overnight at 4°C

• Counterstain with cytoskeletal markers to assess membrane-cytosol translocation

How can I incorporate Phospho-MARCKS (Ser162) Antibody in Phospho-seq or other multiparameter analyses?

For advanced single-cell multiparameter analyses:

• Verify that the antibody works in intracellular flow cytometry or immunocytochemistry with fixed, permeabilized cells

• For Phospho-seq conjugation:

  • Conjugate antibody with DNA-oligo tags using TCO-based chemistry

  • Start with approximately 15 pmol oligo per μg of antibody

  • For older TCO-labeled oligos (>6 months), increase to 20-30 pmol per μg antibody

• The antibody can be used with TSB tags (10X feature barcodes) or TSA tags (Poly A)

• Store conjugated antibodies at 4°C; they remain functional for at least one year

How do I interpret MARCKS phosphorylation patterns in relation to cellular function?

When analyzing MARCKS phosphorylation data:

• Membrane-to-cytosol ratio: Phosphorylation at Ser162 typically causes translocation from membrane to cytosol. In immunofluorescence imaging, quantify the membrane/cytosol intensity ratio .

• Correlation with cellular processes:

  • Increased phosphorylation during inflammation correlates with enhanced migration and adhesion of inflammatory cells

  • During neuronal activation, phosphorylation affects neurite initiation and outgrowth through interactions with CDC42

  • Phosphorylation inhibits PIP2 sequestration, affecting exocytosis

• Comparison with other phosphorylation sites: Compare Ser162 phosphorylation with other sites like Ser152/156 or Ser167/170 to understand site-specific regulation

What are typical confounding factors that might affect data interpretation?

Consider these potential issues when interpreting results:

• Phosphatase activity: Inadequate phosphatase inhibition during sample preparation can lead to false negatives.

• Antibody cross-reactivity: Some phospho-MARCKS antibodies may detect mono-phosphorylated and multi-phosphorylated forms, as noted with the Ser167/170 antibody potentially detecting mono-phosphorylated Ser167 .

• PKC isoform specificity: Different PKC isoforms preferentially phosphorylate MARCKS. In NIH/3T3 fibroblasts, PKC alpha and epsilon, but not delta, are responsible for MARCKS phosphorylation .

• Cell-type variation: MARCKS expression and phosphorylation patterns vary by cell type; macrophages show different patterns than neurons or fibroblasts.

How can Phospho-MARCKS (Ser162) Antibody be used to study the relationship between MARCKS phosphorylation and inflammatory responses?

To investigate MARCKS in inflammation:

• Experimental design: Stimulate cells (especially macrophages) with inflammatory mediators like TNF-α or LPS, which increase PKC-mediated phosphorylation 4-5 fold .

• Analysis approach:

  • Monitor both phosphorylation and cellular location of MARCKS

  • Correlate with cytokine secretion (particularly TNF)

  • Assess reactive oxygen species (ROS) formation, as MARCKS plays an essential role in bacteria-induced intracellular ROS in monocytic cells

  • Examine effects on cell migration, adhesion, and phagocytosis

• Intervention studies: Use PKC inhibitors to block phosphorylation and assess functional consequences for inflammation resolution.

What strategies can be employed to study MARCKS phosphorylation dynamics in live cells?

For dynamic studies of MARCKS phosphorylation:

• Phospho-specific biosensors: Consider complementing antibody-based fixed cell studies with live-cell approaches using FRET-based biosensors for PKC activity or MARCKS conformation.

• Correlative approaches:

  • Fix cells at different time points after stimulation

  • Use the Phospho-MARCKS (Ser162) Antibody with time-course analysis

  • Correlate with functional readouts (calcium imaging, exocytosis, cytoskeletal reorganization)

• Multiparameter imaging: Combine with markers for PIP2, actin, and PKC isoforms to understand the interrelationship between phosphorylation, translocation, and downstream effects.

How can I distinguish between the effects of phosphorylation at different MARCKS serine residues?

To differentiate site-specific phosphorylation effects:

• Multiple phospho-specific antibodies: Use antibodies targeting different phosphorylation sites (Ser152/156, Ser162, Ser167/170) to create a phosphorylation profile .

• Site-directed mutagenesis: Create MARCKS mutants with serine-to-alanine substitutions at specific sites to prevent phosphorylation and analyze functional consequences.

• Phosphorylation sequence analysis: PKC phosphorylates Ser159, 163, 167, and 170 in response to different stimuli like growth factors or oxidative stress . Compare phosphorylation kinetics across these sites.

• Functional correlation:

  • Ser152/156 phosphorylation correlates with certain functions

  • Ser162 phosphorylation may have distinct effects

  • Ser167/170 phosphorylation may regulate different downstream processes

What are potential solutions for weak or absent signal in Western blotting?

If experiencing signal issues:

• Sample preparation:

  • Ensure phosphatase inhibitors are fresh and properly included

  • Avoid sample heating that might activate phosphatases

  • Use fresh lysate or minimize freeze-thaw cycles

• Antibody incubation:

  • Increase antibody concentration (try 1:100 instead of 1:500)

  • Extend incubation time to overnight at 4°C

  • Use BSA instead of milk for blocking and antibody dilution

• Detection system:

  • Use more sensitive detection methods (enhanced chemiluminescence)

  • Consider switching to fluorescent secondary antibodies for better quantification

  • Increase exposure time

• Control experiments:

  • Include positive control (PKC activator-treated cells)

  • Verify target protein expression with total MARCKS antibody

How can I optimize immunofluorescence staining with Phospho-MARCKS (Ser162) Antibody?

For improved immunofluorescence results:

• Fixation optimization:

  • Test both 4% paraformaldehyde and methanol fixation

  • Minimize fixation time to preserve phospho-epitopes

  • Consider dual fixation (brief PFA followed by methanol) for some applications

• Antibody incubation:

  • Use higher antibody concentrations (1:100) for initial optimization

  • Include 0.1% Triton X-100 in antibody dilution buffer to enhance penetration

  • Extend incubation time to 48 hours for thick tissue sections

• Signal enhancement:

  • Consider tyramide signal amplification for weak signals

  • Use conjugated antibodies with bright fluorophores (AF488, AF555, AF594, AF647)

  • Optimize imaging parameters (exposure, gain, offset) for best signal-to-noise ratio

• Background reduction:

  • Include 0.1% Tween-20 in wash buffers

  • Use 5-10% normal serum from secondary antibody host species in blocking buffer

  • Consider adding 0.1-0.3M NaCl to reduce non-specific binding